Left main coronary artery stenosis: A meta-analysis of drug-eluting stents versus coronary artery bypass grafting

JACC: Cardiovascular Interventions

Volumn 6, Issue 12, 2013, Pages 1219-1230

  Athappan, Ganesh ^a   Patvardhan, Eshan ^b   Tuzcu, Murat E ^c   Ellis, Stephen ^c   Whitlow, Patrick ^c   Kapadia, Samir R ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

CABG; long term follow up; PCI with DES; SYNTAX score; UPLMS

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LEFT CORONARY ARTERY; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; CEREBROVASCULAR DISORDERS; CORONARY STENOSIS; MYOCARDIAL INFARCTION; PATIENT SELECTION; RISK; RISK ASSESSMENT; RISK FACTOR; TIME;

CEREBROVASCULAR DISORDERS; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84890693490     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.07.008     Document Type: Article

References (31)

1. M.C. Morice, P.W. Serruys, and A.P. Kappetein Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial Circulation 121 2010 2645 2653
2. E. Boudriot, H. Thiele, and T. Walther Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis J Am Coll Cardiol 57 2011 538 545
3. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
4. Nainggolan L. Surgery is best for most patients, final SYNTAX data confirm. October 31, 2012. Heartwire 2012.
5. M.E. Farkouh, M. Domanski, and L.A. Sleeper Strategies for multivessel revascularization in patients with diabetes New Engl J Med 367 2012 2375 2384
6. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D.F. Stroup Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses Lancet 354 1999 1896 1900
7. D.F. Stroup, J.A. Berlin, S.C. Morton Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group Meta-analysis of observational studies in epidemiology: a proposal for reporting JAMA 283 2000 2008 2012
8. A.P. Amin, J.A. Spertus, and D.J. Cohen Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice Arch Intern Med 172 2012 1145 1152
9. R. DerSimonian, and R. Kacker Random-effects model for meta-analysis of clinical trials: an update Contem Clin Trials 28 2007 105 114
10. B.C. Wallace, C.H. Schmid, J. Lau, and T.A. Trikalinos Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data BMC Med Res Methodol 9 2009 80
11. M. Borenstein, L. Hedges, J. Higgins, and H. Rothstein Comprehensive meta-analysis version 2 2005 Biostat Englewood, NJ
12. D. Capodanno, G.W. Stone, M.C. Morice, T.A. Bass, and C. Tamburino Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data J Am Coll Cardiol 58 2011 1426 1432
13. K. Kajimoto, K. Miyauchi, T. Yamamoto, H. Daida, and A. Amano Meta-analysis of randomized controlled trials on the treatment of unprotected left main coronary artery disease: one-year outcomes with coronary artery bypass grafting versus percutaneous coronary artery intervention with drug-eluting stent J Card Surg 27 2012 152 157
14. M.P. Sa, A.M. Soares, and P.C. Lustosa Meta-analysis of 5,674 patients treated with percutaneous coronary intervention and drug-eluting stents or coronary artery bypass graft surgery for unprotected left main coronary artery stenosis Eur J Cardiothorac Surg 43 2013 73 80
15. P. Wenaweser, J. Daemen, and M. Zwahlen Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
16. Edwards FH, Shahian DM, Grau-Sepulveda MV, et al. Composite analysis of 189,793 Medicare Patients with multi-vessel coronary disease demonstrates a long term advantage for CABG compared to stent placement. Paper presented at: STS 2013-Society of Thoracic Surgeons 49th Annual Meeting; January 29, 2013; Los Angeles, CA. Available at: http://www.sts.org/sites/default/files/documents/pdf/ annmtg/2013AM/49AM-TuesJan29.pdf. Accessed January 29, 2013.
17. Y.H. Kim, D.W. Park, and J.M. Ahn Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study J Am Coll Cardiol Intv 5 2012 708 717
18. G.W. Stone, A. Rizvi, and K. Sudhir Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial J Am Coll Cardiol 58 2011 19 25
19. E. Kedhi, K.S. Joesoef, and E. McFadden Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
20. The EXCEL clinical trial. Clinical Trials ID NCT01205776. Available at: http://www.clinicaltrials.gov/ct2/show/NCT01205776?term=NCT01205776. Accessed January 1, 2013.
21. T. Palmerini, D. Sangiorgi, and A. Marzocchi Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology Eur Heart J 30 2009 2087 2094
22. S.J. Park, Y.H. Kim, and D.W. Park Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis Circ Cardiovasc Intervent 2 2009 167 177
23. R. Albiero, T. Rau, and M. Schluter Comparison of immediate and intermediate-term results of intravascular ultrasound versus angiography-guided Palmaz-Schatz stent implantation in matched lesions Circulation 96 1997 2997 3005
24. P.J. Fitzgerald, A. Oshima, and M. Hayase Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study Circulation 102 2000 523 530
25. K.E. Kip, K. Hollabaugh, O.C. Marroquin, and D.O. Williams The problem with composite end points in cardiovascular studies: The story of major adverse cardiac events and percutaneous coronary intervention J Am Coll Cardiol 51 2008 701 707
26. S. Leonardi, P.W. Armstrong, P.J. Schulte, E.M. Ohman, and L.K. Newby Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review Eur Heart J 34 2013 894 902d
27. K.E. Kip, D.P. Faxon, K.M. Detre, W. Yeh, S.F. Kelsey, and J.W. Currier Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry Circulation 94 1996 1818 1825
28. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) Circulation 96 1997 1761 1769
29. A. Kastrati, A. Schomig, and S. Elezi Predictive factors of restenosis after coronary stent placement J Am Coll Cardiol 30 1997 1428 1436
30. R.W. Yeh, S.L. Normand, and R.E. Wolf Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention Circulation 124 2011 1557 1564
31. A. Kapur, R.J. Hall, and I.S. Malik Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial J Am Coll Cardiol 55 2010 432 440